Fig. 3From: Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategiesDirect exposure to MLT in vivo could lead to toxic side effects such as A nonspecific cell lysis, B hemolysis, C coagulation disorders, and D allergic reactionsBack to article page